SMI Index Under Pressure: How Geopolitics and Silent Crises Are Shaking the Swiss Market Index

When Asian markets close and trading picks up in Zurich, you can literally feel the tension in the air. The news is clear: the Iran war is back on the front page, and the old fear of an escalation in the Gulf casts a shadow over the global economy. For us in Switzerland, a country that lives and dies by global trade, this means: the SMI Index is facing a real stress test. I've spent the last few days studying not just the charts, but also the silent, social, and medical undercurrents currently moving this market. Because anyone just staring at the ticker today is missing the bigger picture.

The oil price as an accelerant for the Swiss Market Index

One thing is clear: a war in the Middle East is never an abstract geopolitical exercise for Switzerland. It hits us directly in the pocket and on the balance sheet. Any professional in this space, which I've been for over two decades, knows: when the Strait of Hormuz gets clogged, the oil price isn't far from the pain threshold. The current forecasts I've looked at among colleagues point to a significant rise in petrol prices – not just in the US, but also at our pumps here. That's not an economic stimulus package, folks. That's a handbrake. A Swiss Market Index heavily influenced by cyclical values like the chemical giants or industrial stocks suffers from rising energy costs. Corporate margins get squeezed, consumer sentiment turns. I remember similar phases: the volatility, measured by the VSMI, the fear barometer of the SIX, will pick up massively in the coming weeks. That's one side of the coin – the obvious one that everyone sees in the chart.

The blind spot: What demographics have to do with stock prices

But the real drivers reshaping the market long-term are much more subtle. Over the last few months, I've been intensely engaged with studies on phenomena that, at first glance, have nothing to do with the SMI Index. For example, the analysis "Sarcopenia in Japanese Elderly with Diabetes: Prevalence and Characteristics". Sounds like geriatric medicine? It is. But it's also highly relevant material for anyone investing in healthcare stocks. The ageing society is a mega-trend that supports our Swiss Market Index. The demand for medication, therapies, and care is rising inexorably. The Swiss pharmaceutical heavyweights, which form the backbone of our index, are perfectly positioned for this. The only question is: are these social and healthcare burdens already fully priced in?

Social media, another topic I picked up on in a recent essay titled "Effects of Social Networks on Medical Comorbidity Among People with Serious Mental Illness", reveals a frightening parallel world. We're talking about the mental health of an entire generation – an issue that becomes systemically relevant. Because a sick, uncertain market participant is an irrational market participant. The classic financial models assuming the Homo Economicus are outdated. I am firmly convinced that we must also attribute the sentiment swings we're currently seeing in the markets – this extreme short-termism – to these psychosocial factors.

Culture, fear, and market behaviour

This brings me to a point I emphasise time and again in my weekly column: Culture is the invisible architect of the market. The essays I'm currently studying (yes, I'm a bookworm when it comes to business) have titles like "Essays on How Cultural Factors Affect the Sentiment and Behavior of Financial Market Participants". And we're experiencing this live right now. The collective fear of a conflagration involving Iran, coupled with uncertain economic prospects, creates a cultural environment of risk aversion. In such a climate, capital flees to safety. And for us in Switzerland, safety is still the SMI Index – but selectively. Investors will continue to view defensive heavyweights like Nestlé or Novartis as safe havens. The cyclical stocks, on the other hand, will suffer.

What does this mean for your strategy?

• Keep an eye on the VSMI: It will reveal the days of panic before prices crash. A rising VSMI is a harbinger of volatility – use it as a signal.
• Focus on quality: In times of the Iran conflict and rising oil prices, companies with high pricing power and solid balance sheets are the winners. The defensive stocks in the Swiss Market Index are your anchor.
• Understand the long-term drivers: The ageing society and the associated healthcare expenditures (think sarcopenia and diabetes) are a structural tailwind for the pharmaceutical giants. Don't let short-term geopolitical shocks deter you from investing in these future trends.

The SMI Index will survive. Our stock exchange has seen plenty of other crises. But the path out of this mix – fear of war here, inflation there, and the silent demographic earthquakes in the background – won't be a straight line. It will be a slide, a twitch, a groping in the dark. And that's precisely what makes this job, even after 20 years, so damn exciting.